Over the last few years, we’ve heard many anecdotal reports claiming NAD+ IVs provide a variety of significant benefits (Link). What about consumer experiences with the new Nicotinamide Riboside “NR” IVs? Here’s a first person account from Jared Burkholder (originally posted on Facebook; reposting with permission):
